Human cervical cancer cell line (HeLa) (ATCC® CCL-2™, Cedarlane) and HEK293 stably expressing the 6xHis-SUMO3-Q87R/Q88N mutant (HEK293-SUMO3m)27 were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (HyClone) supplemented with 10% fetal bovine serum (FBS; Wisent), 1% l-glutamine (Thermo Fisher Scientific), and 1% penicillin/streptomycin (Invitrogen) in 5% CO2 at 37 °C.
The mammalian expression vector for Myc-PIAS1 was constructed by inserting the full-length cDNAs into pcDNA3.0-Myc. The mammalian expression vector for PIAS1-GFP-WT was constructed by cloning full-length PIAS1 cDNA into pcDNA3.1-c-GFP10. The mammalian expression vectors pReceiver-M11 (Flag-NSMCE2, Flag-PFDN2, Flag-VIM, and Flag-empty control) were purchased from Genecopoeia, Inc. (Rockville, MD). The mammalian expression vector Emerald-VIM was purchased from addgene (#54300). The PIAS1-GFP-K137R, PIAS1-GFP-K238R, PIAS1-GFP-K315R and PIAS1-GFP-3XKR, Flag-VIMmt, and Emerald-VIMmt plasmids were generated by site-directed mutagenesis using the GeneArt Site-Directed Mutagenesis System, according to the instructions of the manufacturer (InvitrogenTM). The PIAS CRISPR/Cas9-based gene KO vectors pCRISPR were also purchased from Genecopoeia, Inc. (Rockville, MD). Primer sequences used for vector construction, site-directed mutagenesis, and sgRNA sequences used for CRISPR/Cas9 gene KO are listed below: PIAS1_F: 5′-GGGTACCATGGCGGACAGTGCGGAAC-3′, PIAS1_R: 5′-GGAATTCTCAGTCCAATGAAATAATGTCTGG-3′, PIAS1_K137R_F: 5′-GTCCATCCGGATATAAGACTTCAAAAATTACCA-3′, PIAS1_K137R_R: 5′-TGGTAATTTTTGAAGTCTTATATCCGGATGGAC-3′, PIAS1_K238R_F: 5′-TACCTTCCACCTACAAGAAATGGCGTGGAACCA-3′, PIAS1_K238R_R: 5′-TGGTTCCACGCCATTTCTTGTAGGTGGAAGGTA-3′, PIAS1_K315R_F: 5′-GCTTTAATTAAAGAGAGGTTGACTGCGGATCCA-3′, PIAS1_K315R_R: 5′-CGGATCCGCAGTCAACCTCTCTTTAATTAAAGC-3′, VIM_K439R_F: 5′-GTTGATACCCACTCAAGAAGGACACTTCTGATT-3′, VIM_K439R_R: 5′-AATCAGAAGTGTCCTTCTTGAGTGGGTATCAAC-3′, VIM_K445R_F: 5′-AGGACACTTCTGATTAGGACGGTTGAAACTAGA-3′, VIM_K445R_R: 5′-TCTAGTTTCAACCGTCCTAATCAGAAGTGTCCT-3′, PIAS1-sgRNA: 5′-TTCTGAACTCCAAGTACTGT-3′, PIAS2-sgRNA: 5′-CAAGTATTACTAGGCTTTGC-3′, PIAS3-sgRNA: 5′-GCCCTTCTATGAAGTCTATG-3′, PIAS4-sgRNA: 5′-GGCTTCGCGCCGTAGTCTTAG-3′, and scrambled sgRNA: 5′-GGCTTCGCGCCGTAGTCTTA-3′.
For transient transfection, cells were transfected with 1 μg plasmid per million cells using JetPrime Reagent (Polyplus transfection) according to the manufacturer’s protocol. Cells were collected 36 h or 48 h after transfection for further experiments and protein overexpression was confirmed by western blotting.
For PIAS gene KO, cells were transfected with 1 μg plasmid per million cells using JetPrime Reagent (Polyplus transfection) according to the manufacturer’s protocol. Cells were sorted by fluorescence-activated cell sorting based on Red fluorescent proteins-mCherry signals 48 h after transfection. mCherry-positive cells were cultured and expended for another week (Supplementary Fig. 1). PIAS KO efficiency was confirmed by western blotting.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.